US Stock MarketDetailed Quotes

SLRN Acelyrin

Watchlist

2.600
+0.030+1.17%

Close Feb 26 16:00 ET

2.580
-0.020-0.77%

Pre 08:00 ET

260.85MMarket Cap-0.98P/E (TTM)

Acelyrin Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Acelyrin Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
Nov 13, 2024	2024/Q3	0.000 / 0.000	--
Aug 13, 2024	2024/Q2	0.000 / 0.000	--
May 13, 2024	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

Nov 13, 20242024/Q30.000 / 0.000--

Aug 13, 20242024/Q20.000 / 0.000--

May 13, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Acelyrin Earnings Reports

Acelyrin | 10-Q: Q3 2024 Earnings Report

Nov 13, 2024 16:10 ET

Acelyrin | 8-K: ACELYRIN, INC. Reports Third Quarter 2024 Financial Results and Recent Highlights

Nov 13, 2024 16:09 ET

Acelyrin | 10-Q: Q2 2024 Earnings Report

Aug 13, 2024 16:24 ET

Acelyrin | 8-K: ACELYRIN, INC. Announces Positive Phase 3 Data for Izokibep in Hidradenitis Suppurativa; Focuses Strategy on Lonigutamab and Reports Second Quarter 2024 Financial Results

Aug 13, 2024 16:18 ET